You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adult leukemias and myelodysplasia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Acute Myeloid Leukemia, Myelodysplasia Trial in United States (MGTA-117)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • MGTA-117
  • Duarte, California
  • +7 more
Nov 23, 2022

Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

Recruiting
  • Leukemia, Acute
  • +3 more
  • Palliative Care Visits
  • Charlottesville, Virginia
    University of Virginia
Apr 28, 2022

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Jan 18, 2023

    Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

    Terminated
    • Acute Myelogenous Leukemia in Relapse
    • +4 more
    • Tucson, Arizona
    • +12 more
    Aug 18, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

    Completed
    • Minimal Residual Disease
    • +3 more
    • Daratumumab
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 2, 2022

    AML/MDS Trial in Worldwide (Decitabine, Midostaurin)

    Active, not recruiting
    • AML/MDS
    • Antwerpen, Belgium
    • +36 more
    Dec 29, 2021

    Aml, AML, Adult Trial (Nivolumab, Azacitidine)

    Withdrawn
    • Aml
    • AML, Adult
    • (no location specified)
    Oct 9, 2020

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • +19 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Lewes, Delaware
      • +16 more
      Aug 3, 2022

      Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

      Completed
      • Cutaneous T-cell Lymphoma (CTCL)
      • +4 more
      • Duarte, California
      • +18 more
      Nov 19, 2020

      Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )

      Recruiting
      • Acute Myeloid Leukemia
      • Myelodysplasia
      • Oral azacitidine
      • Matched placebo
      • Birmingham, United Kingdom
      • +20 more
      Oct 14, 2021

      Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

      Recruiting
      • Non Malignant Diseases
      • +2 more
      • RIC: Distal Campath
      • +2 more
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Mar 8, 2022

      MDS, Acute Myeloid Leukemia Trial in New Haven (AG-120, Nivolumab)

      Withdrawn
      • Myelodysplastic Syndromes
      • Acute Myeloid Leukemia
      • New Haven, Connecticut
        Yale Cancer Center
      Jan 6, 2022

      High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)

      Recruiting
      • High Risk Hematologic Malignancy
      • Cord Blood Transplant
      • Transplant with an expanded ECT-001 cord blood
      • Montréal, Quebec, Canada
        CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
      Aug 2, 2021

      Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

      Recruiting
      • Acute Myeloid Leukemia
      • +8 more
      • Ghent, Belgium
      • +28 more
      Nov 11, 2022

      MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Subcutaneous azacitidine
      • Oral decitabine/cedazuridine
      • Newcastle, New South Wales, Australia
        Calvary Mater Newcastle
      May 29, 2023

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +13 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 2, 2023

      Leukemia Trial in New York, Durham, Allentown (drug, other, device)

      Active, not recruiting
      • Leukemia
      • New York, New York
      • +3 more
      Sep 1, 2021

      A Post-Marketing Observational Study of VYXEOS™

      Completed
      • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
      • Therapy-Related Acute Myeloid Leukemia
      • Indianapolis, Indiana
      • +6 more
      Aug 4, 2020